0001410442-20-000008.txt : 20201013
0001410442-20-000008.hdr.sgml : 20201013
20201013160446
ACCESSION NUMBER: 0001410442-20-000008
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201009
FILED AS OF DATE: 20201013
DATE AS OF CHANGE: 20201013
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jain Vivek
CENTRAL INDEX KEY: 0001410442
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34634
FILM NUMBER: 201236304
MAIL ADDRESS:
STREET 1: ICU MEDICAL, INC.
STREET 2: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ICU MEDICAL INC/DE
CENTRAL INDEX KEY: 0000883984
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330022692
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
BUSINESS PHONE: 949-366-2183
MAIL ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-10-09
0
0000883984
ICU MEDICAL INC/DE
ICUI
0001410442
Jain Vivek
951 CALLE AMANECER
SAN CLEMENTE
CA
92673
1
1
0
0
Chairman and CEO
Common Stock
2020-10-09
4
M
0
11500
58.79
A
77741
D
Common Stock
2020-10-09
4
S
0
11500
195.0
D
66241
D
Non-Qualified Stock Option (right to buy)
58.79
2020-10-09
4
M
0
11500
0.0
D
2024-02-24
Common Stock
11500
447866
D
The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2020.
All shares sold were sold at the exact price disclosed.
Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the vesting commencement date of February 13, 2014. Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of the exercise price for 30 consecutive trading days.
By: Paula Darbyshire, Attorney-in-fact For: Vivek Jain
2020-10-13